A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcinoma
Conditions: Cervical Cancer Interventions: Biological: Nimotuzumab; Drug: Cisplatin; Radiation: External Beam Radiotherapy (EBRT); Radiation: Brachytherapy; Drug: placebo for Nimotuzumab Sponsors: Biotech Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials
Hypofractionated Radiochemotherapy
Conditions: Uterine Cervix Cancer Interventions: Drug: Cisplatin; Radiation: intensity modulated radiation therapy (IMRT); Radiation: high-dose-rate (HDR) brachytherapy Sponsors: Denise Fabian Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Association Between Surgical Timing and Route of Total Hysterectomy After LEEP and Perioperative Risk in Patients With Cervical HSIL
Conditions: High-Grade Squamous Intraepithelial Lesions Interventions: Procedure: surgical timing and operation path Sponsors: Sichuan Cancer Hospital and Research Institute Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique
Conditions: HIV Infections; HPV Infection; CIN 2/3 Interventions: Device: Thermal ablation; Procedure: LOOP ELECTROSURGICAL EXCISION PROCEDURE Sponsors: Instituto Nacional de Sa úde, Mozambique; M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
Conditions: HPV-Related Cervical Carcinoma; HPV Positive Oropharyngeal Squamous Cell Carcinoma Interventions: Drug: Two IM injections Lenti-HPV-07; Drug: One IM injection Lenti-HPV-07 Sponsors: Theravectys S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients
Conditions: Cervical Cancer Interventions: Drug: PVX7 Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; National Institutes of Health (NIH) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
Safety of Effivia ®, a Bevacizumab Biosimilar
Conditions: Metastatic Colorectal Cancer; Metastatic Cervical Cancer; Non Squamous Non Small Cell Lung Cancer Interventions: Drug: Bevacizumab Biosimilar MB02 Sponsors: Laboratorios Liomont; Servicios Especializados en Ensayos Cl ínicos, S.C. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Hospital-based Validation of the New ELEVATE Screening Tool in Belgium and Ecuador
Conditions: Cervical Cancer; HPV Infection Interventions: Behavioral: Questionnaire; Procedure: HPV self-sample; Procedure: Endocervical sample Sponsors: University Hospital, Ghent; Horizon 2020 - European Commission; Universidad de Cuenca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials
Myeloprotection With Trilaciclib in Pan-cancer Population
Conditions: Non-Small Cell Lung Cancer; Breast Cancer; Endometrial Cancer; Cervical Cancer; Head And Neck Squamous Cell Carcinomas Interventions: Drug: Trilaciclib Injection; Drug: Paclitaxel; Drug: Carboplatin Sponsors: Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Conditions: Endometrial Cancer; Cervical Cancer; Ovarian Cancer; Urothelial Carcinoma; Biliary Tract Cancer Interventions: Drug: BL-M07D1 Sponsors: SystImmune Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2024 Category: Research Source Type: clinical trials
Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
Conditions: HPV Infection; Cervical Cancer Interventions: Other: Cold physical Plasma; Other: Control group Sponsors: University Hospital Tuebingen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer
Conditions: Cervical Cancer; Neoadjuvant Chemoimmunotherapy; Radical Hysterectomy; Fertility Preservation Interventions: Drug: Cadonilimab; Drug: Paclitaxel-albumin; Drug: Cisplatin; Procedure: Extrafascial hysterectomy Sponsors: Tongji Hospital; The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial); Women Hospital, School of Medicine, Zhejiang University; Southwest Hospital, China; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Sichuan Cancer Hospital and Research Institute; Qilu Hospital of Shandong University; Beijing Friendship Hospital; Tianjin Medical University; Wes...
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC
Conditions: Cervical Cancer; Locally Advanced Cervical Cancer; Concurrent Chemoradiotherapy; Neoadjuvant Chemoimmunotherapy Interventions: Drug: Camrelizumab; Drug: Cisplatin; Drug: Nab paclitaxel; Procedure: Radical surgery; Radiation: external beam radiation therapy (EBRT) + brachytherapy; Drug: Cisplatin Sponsors: Tongji Hospital; Southwest Hospital, China; Women Hospital, School of Medicine, Zhejiang University; Anhui Provincial Cancer Hospital; Sichuan Cancer Hospital and Research Institute; Qilu Hospital of Shandong University; Beijing Friendship Hospital; Tianjin Medical University General Hospital; West China Secon...
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer
Conditions: Cervical Cancer; Neoadjuvant Chemoimmunotherapy; Fertility Preservation Interventions: Drug: Camrelizumab; Drug: Cisplatin; Drug: Nab paclitaxel; Procedure: biopsy Sponsors: Tongji Hospital; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Women Hospital, School of Medicine, Zhejiang University; Third Military Medical University; Beijing Friendship Hospital; Sichuan Cancer Hospital and Research Institute; Tianjin Medical University; West China Second University Hospital; Xiangya Hospital of Central South University; Qilu Hospital of Shandong University; Gansu Cancer Hospital; Zhejiang Cancer Hospital; S...
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
Neoadjuvant Immunochemotherapy in PD-L1-negative LACC
Conditions: Cervical Cancer; Locally Advanced Cervical Cancer; PD-L1 Negative; Neoadjuvant Chemoimmunotherapy Interventions: Drug: Camrelizumab; Drug: Paclitaxel-albumin; Drug: Cisplatin; Procedure: radical surgery Sponsors: Tongji Hospital; Southwest Hospital, China; Women Hospital, School of Medicine, Zhejiang University; Anhui Provincial Cancer Hospital; Sichuan Cancer Hospital and Research Institute; Gansu Provincial Maternal and Child Health Care Hospital; Beijing Friendship Hospital; Tianjin Medical University General Hospital; Xiangya Hospital of Central South University; West China Second University Hospital; Sun Y...
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
